Valuation eFFECTOR Therapeutics, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 10:33:11 2026-05-29 EDT			5-day change	1st Jan Change
0.000600 ^USD	+20.00%		-.--%	+200.00%

24-09-10	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
24-07-07	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	3/16/22	3/8/23	3/26/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
EFFECTOR THERAPEUTICS, INC.	-	-	-	-	940
WUXI APPTEC CO., LTD.	21.08x	6.49x	14.2x	1.51%	55.92B
ARGENX SE	33.57x	8.33x	25.41x	0.06%	56.67B
BIONTECH SE	-18.45x	4.44x	-7.77x	-.--%	23.28B
INSMED INCORPORATED	-42.05x	13.36x	-39.35x	-.--%	23.28B
WUXI BIOLOGICS (CAYMAN) INC.	25.7x	5.07x	13.38x	-.--%	20.54B
GENMAB A/S	24.87x	4.83x	15.68x	-.--%	17.78B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-617.89x	37.85x	-1571.42x	-.--%	15.9B
PHARMAESSENTIA CORPORATION	44.16x	17.85x	45.97x	0.08%	14.64B
EXELIXIS, INC.	17.51x	5.07x	11.83x	-.--%	13.99B
Average	-56.83x	11.48x	-165.79x	0.18%	24.2B
Weighted average by Cap.	-25.98x	9.81x	-92.78x	0.37%